Últimas noticias sobre NFT (AMEX:MI) Bolsa

NFT Ltd Formerly Takung Art Co Ltd operates an online electronic platform for offering and trading artwork. Through its platform, the company allows artists/art dealers/owners to access a much bigger art trading market where artists can engage with a wide range of investors. Its platform also invests in high-end artwork accessible to ordinary people without financial resources. The company's trading platforms comprise the sale of calligraphies and paintings, jewelry, and precious stones. It generates revenue in the form of services in connection with the offering and trading of artwork on its system, consisting of listing fees, trading commissions, and management fees.

NFT Ltd

Minto Apartment REIT

MIAMI BREEZE CAR CARE INC by Miami Breeze Car Care, Inc.

Millicom International Cellular SA SDR

MINT Income Fund

Mycronic AB

Micron Solutions Inc

MICRON SOLUTIONS INC NEW by Micron Solutions, Inc.

American Century Mid Cap Growth Impact ETF

The Middleby Corp

Xtrackers S&P MidCap 400 ESG ETF

Midland Exploration Inc

Direxion Mid Cap Bull 3X Shares

MITSUBISHI ELEC CORP by Mitsubishi Electric Corp.

Mitsubishi Electric Corp

MITSUBISHI ELEC UNSP/ADR by Mitsubishi Electric Corp.

MITSUI E&S HLDGS CO LTD by Mitsui E&S Co Ltd.

Mitsui E&S Co Ltd

MITSUI E&S CO LTD U/ADR by Mitsui E&S Co Ltd.

MIFFLINBURG BANCORP INC by Mifflinburg Bancorp, Inc.

Mifflinburg Bancorp Inc

MILLENNIUM FD TECH UT NEW by MILLENNIUM FOOD TECH LTD.

Millenium Food-Tech-Ltd Partnership

VanEck Moody's Analytics IG Corporate Bond ETF

Mawson Infrastructure Group Inc. - Common Stock

Mawson Infrastructure Group Inc

MISC Bhd

MONTAGUE INTL HLDGS LTD by MONTAGUE INTERNATIONAL HOLDING LTD.

Montague International Holding Ltd

MITRA KELUARGA KARYASEHAT by Mitra Keluarga Karyasehat TBK PT

PT Mitra Keluarga Karyasehat Tbk

MIKE THE PIKE PRODS INC by Mike The Pike Productions, Inc.

Mike The Pike Productions Inc

MILLENNIUM SUSTAINALE VTR by Millennium Sustainable Ventures Corp.

Millennium Sustainable Ventures Corp

1CM Inc

MITSUBISHI LOGISTICS CORP by Mitsubishi Logistics Corp.

Mitsubishi Logistics Corp

MILITARY METALS CORP by MILITARY METALS CORP.

Military Metals Corp

Pacer Funds Trust Pacer US Cash Cows Bond ETF

Global X Millennial Consumer ETF

Mobilicom Ltd

Magic Internet Money - United States Dollar

MAI - United States Dollar

MIMEDIA HLDGS INC SUB VTG by MiMedia Holdings Inc.

Mint Incorporation Limited - Class A Ordinary Shares

Mint Inc Ltd

Airspan Networks Holdings Inc

Airspan Networks Holdings Inc Warrants - Class C (01/11/2026)

MITSUBISHI MATERIALS ORD by Mitsubishi Materials Corp.

Mitsubishi Materials Corp

Airspan Networks Holdings Inc Warrants (01/11/2026)

Nighthawk Gold Corp

MFS Intermediate Income Trust Common Stock

MFS Intermediate Income Trust

Mina Protocol - United States Dollar

MINEBEA MITSUMI INC U/ADR by Minebea Mitsumi Inc.

Minebea Mitsumi Inc

MIND Technology Inc

MIND Technology Inc 9 % Conv Pfd Registered Shs Series -A-

Minerco Inc

Minim Inc

Trust for Professional Managers Mairs & Power Minnesota Municipal Bond ETF

PIMCO Municipal Income Opportunities Active Exchange-Traded Fund

MINOR INTL PCL ORD by Minor International Public Co., Ltd.

Minor International PCL

Minerva Gold Inc

Minor International PCL Warrants Series - 7 (31/07/2023)

PIMCO Enhanced Short Maturity Active Exchange-Traded Fund

Mint Club

MintMe.com Coin

Matthews International Funds Matthews Asia Innovators Active ETF

MERCANTILE INVST TR NEW by Mercantile Investment Trust PLC

Pioneer Municipal High Income Opportunities Fund, Inc. Common Stock

Pioneer Municipal High Income Opportunities Fund Inc.

Milbon Co Ltd

IOTA

MINOR INTL PUB CO LTD by Minor International Public Co., Ltd.

Mirion Technologies, Inc. Class A Common Stock

Mirion Technologies Inc

Mirror Protocol - United States Dollar

MIRA Pharmaceuticals, Inc. - Common Stock

Mira Pharmaceuticals Inc

MIRAI Corp

Mirum Pharmaceuticals, Inc. - common stock

Mirum Pharmaceuticals Inc

Miromatrix Medical Inc

SERRANO RES LTD by Serrano Resources Ltd.

Serrano Resources Ltd

First Trust Exchange-Traded Fund First Trust Indxx Aerospace & Defense ETF

Milestone Pharmaceuticals Inc. - Common Shares

Milestone Pharmaceuticals Inc

Mist

Minco Silver Corp

MITSUBISHI ESTATE CO by Mitsubishi Estate Co. Ltd.

Mitsubishi Estate Co Ltd

MITSUBISHI EST UNSP/ADR by Mitsubishi Estate Co. Ltd.

MITIE Group PLC

MITIE GROUP PLC UNSP/ADR by Mitie Group Plc.

Mithril

Mitesco Inc

MINT CORPORATION (THE) by Mint Corporation (The)

The Mint Corp

Mitek Systems Inc

AG Mortgage Investment Trust, Inc. 9.500% Senior Notes due 2029

MI TECHNOVATION BERHAD by MI TECHNOVATION BERHAD

MI Technovation Bhd

MITHRA PHARMACEUTICALS SA by MITHRA PHARMACEUTICALS SA

Mithra Pharmaceuticals SA

Moving iMage Technologies, Inc. Common Stock

Moving iMage Technologies Inc

MITSUI & CO LTD ORD by Mitsui & Co., Ltd.

Mitsui & Co Ltd

MITSUI & CO LTD ADR by Mitsui & Co., Ltd.

AG Mortgage Investment Trust, Inc. Common Stock

AG Mortgage Investment Trust Inc

AG Mortgage Investment Trust, Inc. 8.25% Preferred Series A

AG Mortgage Investment Trust, Inc. Preferred Series B

AG Mortgage Investment Trust, Inc. 8.00% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock, $0.01 par value per share

MITSUI CHEMICALS INC NEW by Mitsui Chemicals Inc.

Mitsui Chemicals Inc

Scotiabank analyst Nicholas Yulico maintains Realty Income (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/O#NYSE">O</a>) with a Sector Perform and lowers the price target from $61 to $59.

News

Price Target

Analyst Ratings

Scotiabank Maintains Sector Perform on Realty Income, Lowers Price Target to $59

The board of directors of&nbsp;WEC Energy Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WEC#NYSE">WEC</a>) today declared a quarterly cash dividend of 89.25 cents per share on the company's common stock, an increase of 6.9 percent over the current quarterly dividend of 83.50 cents per share. This raises the annual dividend rate to $3.57 per share.
The higher dividend is payable March 1, 2025, to stockholders of record on Feb. 14, 2025. This marks the 330th&nbsp;consecutive quarter — dating back to 1942 — that the company will have paid a dividend to its stockholders.

Dividends

WEC Energy Group Raises Quarterly Dividend From $0.8350 To $0.8925

KLA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLAC#NASDAQ">KLAC</a>) shares are ripping higher on Thursday. They are trading in sympathy with Taiwan Semiconductor Manufacturing Company Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>), which reported earnings ahead of estimates.
But KLA Corporation may be about to reverse and head lower. This is why our team of technical analysts has made it our Stock of the Day.
Momentum is a measurement of how far a stock has moved up or down in a given period of time. Most of the time, a stock will stay in its typical or usual trading range.
If sellers are aggressive and push the price below this range, traders say it is oversold. If buyers push the price above the range, traders say it is overbought.
These are important dynamics. Many trading strategies are based on the concept of reversion to the mean. Stocks that are overbought or oversold tend to reverse back into their average trading ranges.
There are dozens and maybe even hundreds of different ways to measure a stock's momentum. These are called momentum indicators or oscillators.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="550" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16144506/KLACorp-1024x550.png" alt="" class="wp-image-737613" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16144506/KLACorp-1024x550.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16144506/KLACorp-300x161.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16144506/KLACorp-768x412.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16144506/KLACorp.png 1527w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/43036902/tesla-stock-valuation-analyst-flags-long-term-growth-opportunities-robotaxis-fsd">Tesla Stock &#8216;Valuation Is Full&#8217;: Analyst Flags Long-Term Growth Opportunities With Robotaxis, FSD</a>
Some new traders make the mistake of using too many of these indicators. They believe that the more they study, the better their results will be.
But sometimes a trader would be better off just using a few and mastering them.
The lower part of the chart is the Relative Strength Momentum Indicator (RSI). This is a popular indicator. When the blue line is higher than the horizontal red line, it indicates overbought conditions.  As you can see, that is the case now.
The red line on the price chart is called a Bollinger Band. It is another popular way to measure momentum.
The line is two standard deviations above the 20-day moving average. Statistics and probability theory suggest that 95% of trading should occur within two standard deviations of the mean.
If the stock exceeds this threshold, it is considered to be overbought. As you can see, that is the case now.
The last two times <a href="https://www.benzinga.com/quote/KLAC">KLA Corporation</a> was shown to be overbought simultaneously by both of these indicators, a sell-off followed soon after. It may be about to happen again.
Read Next: • <a href="https://www.benzinga.com/general/travel/25/01/43036258/polar-vortex-brings-winters-coldest-air-for-trumps-inauguration-day-what-it-means-for-utilities-retailers-energy-stocks">Polar Vortex Brings Winter&#8217;s Coldest Air For Trump&#8217;s Inauguration Day: What It Means For Utilities, Retailers, Energy Stocks</a>
Photo: JHVEPhoto via Shutterstock

Technicals

Tech

Trading Ideas

KLAC

Stock Of The Day: Is KLA Corporation's Rally About To End?

Scotiabank analyst Greg McGinniss maintains Gaming and Leisure Props (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLPI#NASDAQ">GLPI</a>) with a Sector Perform and lowers the price target from $50 to $49.

GLPI

Scotiabank Maintains Sector Perform on Gaming and Leisure Props, Lowers Price Target to $49

On Thursday, <a href="https://www.benzinga.com/topic/spruce-point-capital">Spruce Point Capital released</a> a detailed report on PROCEPT BioRobotics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRCT#NASDAQ">PRCT</a>), raising concerns about the claims surrounding its market potential and growth prospects, suggesting the company&#8217;s stock could face a 30% to 60% downside.
Spruce Point questions the credibility of Procept&#8217;s addressable market estimates, business metrics, and valuation.
Procept BioRobotics specializes in a robotic surgical system for benign prostatic hyperplasia (BPH or enlarged prostate).
Benzinga has contacted Procept for comment on the Spruce Point report and will update if a response is received.
The company&#8217;s Aquablation therapy, a waterjet procedure designed to minimize sexual side effects compared to other surgeries, has gained traction in high-volume U.S. hospitals, contributing to significant revenue growth—from under $10 million in 2020 to $200 million, according to Spruce Point.
However, Spruce Point argues that Procept's comparison to Intuitive Surgical Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) is misleading and that the addressable market for Aquablation is significantly overstated.
Also Read: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41583831/surgical-robotics-provider-procept-biorobotics-q3-earnings-beats-street-view-analys" target="_blank" rel="noreferrer noopener">Surgical Robotics Provider PROCEPT BioRobotics&#8217; Q3 Earnings Beats Street View, Analyst Optimistic About Upside Potential</a>
Spruce Point <a target="_blank" href="https://www.businesswire.com/news/home/20250116281668/en/Spruce-Point-Capital-Management-Announces-Investment-Opinion-Releases-Report-and-Strong-Sell-Research-Opinion-on-PROCEPT-BioRobotics-NASDAQ-PRCT" rel="noreferrer noopener">writes</a> that Aquablation&#8217;s appeal is limited to a niche segment of patients with large prostates, representing only a small fraction of the BPH market. Most BPH patients suffer from mild to moderate symptoms, often managed with medications or minimally invasive surgical therapies (MISTs).
These outpatient procedures, offering minimal risks and shorter recovery times, have rapidly gained market share since 2014, accounting for 40-45% of BPH surgeries. Spruce Point says MISTs will continue to outpace resective procedures like Aquablation.
Further concerns stem from Procept's rising days sales outstanding (DSOs), which have increased from 47 to 130 days over three years, signaling potential sales and accounting issues.
Spruce Point also found inconsistencies in Procept's reported surgical volumes and equipment utilization rates, raising doubts about the company's metrics.
Procept&#8217;s statements regarding its robotic and AI capabilities have faced scrutiny. Critics, including Spruce Point Capital Management, argue that the system&#8217;s reliance on sales representatives during procedures and the need for surgeon expertise undermines its &#8220;automation&#8221; narrative. The HYDROS system, introduced with promises of AI-driven advancements, has been met with mixed feedback, with some urologists finding its features underwhelming.
Despite Procept&#8217;s $4.7 billion market valuation and premium revenue multiple, Spruce Point argues that its niche product, structural barriers to growth, and questionable metrics make its valuation unsustainable. The firm estimates Procept's fair value at $29 to $54 per share, implying substantial downside risk.
Price Action: PRCT stock is down 1.79% at $76.91 at last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/43034421/whats-going-on-with-rtx-corporation-stock-today" target="_blank" rel="noreferrer noopener">RTX Lands $529M Contract To Bolster Dutch Missile Defense: Details</a></li>
</ul>
Photo: Shutterstock

Short Sellers

Short Ideas

Health Care

General

ISRG

PRCT

Spruce Point Sees Trouble Ahead For Procept BioRobotics

Scotiabank analyst Allan Verkhovski maintains Monday.Com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>) with a Sector Outperform and lowers the price target from $325 to $300.

MNDY

Scotiabank Maintains Sector Outperform on Monday.Com, Lowers Price Target to $300

Wingstop's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WING#NYSE">WING</a>) short percent of float has fallen 3.55% since its last report. The company recently reported that it has 1.74 million shares sold short, which is 5.98% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.59 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Wingstop Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737056724_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Wingstop has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Wingstop's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Wingstop's peer group average for short interest as a percentage of float is 9.30%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

WING

Looking Into Wingstop's Recent Short Interest

Navitas Semiconductor's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVTS#NYSE">NVTS</a>) short percent of float has risen 16.42% since its last report. The company recently reported that it has 29.11 million shares sold short, which is 22.62% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.64 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Navitas Semiconductor Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737056719_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Navitas Semiconductor has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Navitas Semiconductor's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Navitas Semiconductor's peer group average for short interest as a percentage of float is 9.51%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

NVTS

Peering Into Navitas Semiconductor's Recent Short Interest

TD Synnex's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNX#NYSE">SNX</a>) short percent of float has fallen 29.05% since its last report. The company recently reported that it has 1.44 million shares sold short, which is 2.54% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.88 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>TD Synnex Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737056714_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for TD Synnex has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing TD Synnex's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, TD Synnex's peer group average for short interest as a percentage of float is 4.88%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into TD Synnex's Recent Short Interest

<a href="https://x.com/mingchikuo/status/1879956827376685088" title="https://x.com/mingchikuo/status/1879956827376685088">https://x.com/mingchikuo/status/1879956827376685088</a>

NVDA

Analyst Ming-Chi Kuo Posts On X "TSMC's excellent financial result supports the positive AI trend. However, concerns remain regarding the shipment of Nvidia's GB200 NVL72. It might seem contradictory, but it's not. The key lies in TSMC's advanced nodes, a scarce resource highly sought by all global customers. Therefore, short-term underperformance of a single customer or product isn't likely to significantly impact TSMC's business momentum. On the contrary, TSMC often outperforms the industry average..."

Israel's cabinet will reportedly vote on a ceasefire agreement <a href="https://www.benzinga.com/25/01/43011383/israel-gaza-ceasefire-hostage-exchange">with Hamas on Friday.</a>
Since the announcement of the tentative truce on Wednesday, Israeli airstrikes in Gaza have reportedly killed 83 people, according to a spokesperson for Gaza's Civil Defense, marking the highest daily toll in over a week, <a href="https://www.cnn.com/world/live-news/israel-hamas-gaza-ceasefire-hostages-01-16-24/index.html">CNN</a> reports.
What Happened: The ceasefire proposal, brokered after extensive negotiations, aims to halt the ongoing conflict in Gaza and facilitate the release of hostages held by Hamas in exchange for Palestinian prisoners. Prime Minister Benjamin Netanyahu has refrained from commenting on specific deal provisions until all elements are finalized, CNN said. 
Tnsions within Netanyahu's coalition government are escalating. A key right-wing faction has threatened to withdraw its support unless the ceasefire's initial phase leads to a resumption of military operations.
According to CNN, international humanitarian agencies have welcomed the deal, urging unfettered access to Gaza to address the extensive humanitarian crisis.
Also Read: <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43017610/oil-prices-break-80-reach-6-month-highs-despite-israel-hamas-ceasefire-deal-why-is-crude-rallying">Oil Prices Break $80, Reach 6-Month Highs Despite Israel-Hamas Ceasefire Deal: Why Is Crude Rallying?</a>
Why It Matters: With the ceasefire on shaky ground, Netanyahu's decision to <a href="https://www.benzinga.com/news/global/25/01/43029992/netanyahu-postpones-ceasefire-vote-raising-questions-about-gaza-truce-prospects">delay the cabinet vote</a> — citing additional demands by Hamas — raises questions about the agreement's durability. Senior Hamas official Sami Abu Zuhri has denied allegations of reneging on the deal, calling the claims baseless.
The dispute has cast doubt on the potential end to a 15-month conflict.
International mediators remain hopeful, emphasizing the significance of the agreement in alleviating the humanitarian toll in Gaza. 
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/42933339/trumps-envoy-urges-netanyahu-for-gaza-deal-can-ceasefire-efforts-succeed-before-inauguration">Trump&#8217;s Envoy Presses Netanyahu for Gaza Deal: Can Ceasefire Push Succeed Before Inauguration?</a></li>
</ul>
Photo: Shutterstock.

Global

Israel Cabinet Reportedly Set To Vote On Gaza Truce Friday

Scotiabank analyst Greg Harrison maintains Keros Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KROS#NASDAQ">KROS</a>) with a Sector Outperform and lowers the price target from $44 to $41.

KROS

Scotiabank Maintains Sector Outperform on Keros Therapeutics, Lowers Price Target to $41

Benzinga's options scanner just detected over 9 options trades for NextDecade (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEXT#NASDAQ">NEXT</a>) summing a total amount of $1,381,889.
At the same time, our algo caught 2 for a total amount of 71,571.
<h3>What's The Price Target?</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $4.0 to $8.0 for NextDecade during the past quarter. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for NextDecade's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of NextDecade's whale trades within a strike price range from $4.0 to $8.0 in the last 30 days. 
<h3>NextDecade Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737056003_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NEXT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$3.6</td>
<td>$3.5</td>
<td>$3.6</td>
<td>$5.00</td>
<td>$713.4K</td>
<td>26.3K</td>
<td>2.6K</td>
</tr>
<tr>
<td>NEXT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$1.65</td>
<td>$1.6</td>
<td>$1.65</td>
<td>$7.00</td>
<td>$251.1K</td>
<td>7.3K</td>
<td>1.5K</td>
</tr>
<tr>
<td>NEXT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$3.6</td>
<td>$3.5</td>
<td>$3.6</td>
<td>$5.00</td>
<td>$214.6K</td>
<td>26.3K</td>
<td>614</td>
</tr>
<tr>
<td>NEXT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$4.6</td>
<td>$4.3</td>
<td>$4.3</td>
<td>$4.00</td>
<td>$86.0K</td>
<td>249</td>
<td>200</td>
</tr>
<tr>
<td>NEXT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$1.7</td>
<td>$1.55</td>
<td>$1.65</td>
<td>$7.00</td>
<td>$50.6K</td>
<td>7.3K</td>
<td>1.9K</td>
</tr>
</tbody>
</table>

<h3>About NextDecade</h3>
NextDecade Corp is a energy company predominantly engaged in construction and development activities related to the liquefaction of natural gas and sale of LNG and the capture and storage of CO2 emissions. The company provides a number of services depending on the individual needs of the customer. These include the supply and trade of LNG volumes, the creation of new natural gas infrastructure including pipeline and natural gas liquefaction facilities, treatment and processing of natural gas into LNG, as well as technical engineering and design services related to the development and execution of natural gas infrastructure, transporting, shipping and storage of LNG.
Following our analysis of the options activities associated with NextDecade, we pivot to a closer look at the company's own performance.
<h3>Where Is NextDecade Standing Right Now?</h3>
<ul>
<li>With a volume of 4,321,781, the price of NEXT is down -1.73% at $7.96. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 53 days.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for NextDecade with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

Markets

Behind the Scenes of NextDecade's Latest Options Trends

Investors with a lot of money to spend have taken a bullish stance on EOG Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EOG#NYSE">EOG</a>).
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with EOG, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 8 options trades for EOG Resources.
This isn't normal.
The overall sentiment of these big-money traders is split between 50% bullish and 37%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $35,000, and 7, calls, for a total amount of $489,627.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $120.0 to $150.0 for EOG Resources over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of EOG Resources stands at 541.83, with a total volume reaching 1,571.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in EOG Resources, situated within the strike price corridor from $120.0 to $150.0, throughout the last 30 days.
<h3>EOG Resources Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737055998_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>EOG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/31/25</td>
<td>$16.4</td>
<td>$16.4</td>
<td>$16.4</td>
<td>$121.00</td>
<td>$145.9K</td>
<td>115</td>
<td align="right">27</td>
</tr>
<tr>
<td>EOG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$13.9</td>
<td>$12.6</td>
<td>$12.81</td>
<td>$124.50</td>
<td>$73.9K</td>
<td>395</td>
<td align="right">55</td>
</tr>
<tr>
<td>EOG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/28/25</td>
<td>$4.8</td>
<td>$4.3</td>
<td>$4.4</td>
<td>$137.00</td>
<td>$70.8K</td>
<td>15</td>
<td align="right">161</td>
</tr>
<tr>
<td>EOG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/31/25</td>
<td>$15.4</td>
<td>$15.4</td>
<td>$15.4</td>
<td>$122.00</td>
<td>$70.8K</td>
<td>62</td>
<td align="right">46</td>
</tr>
<tr>
<td>EOG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$10.0</td>
<td>$9.3</td>
<td>$9.3</td>
<td>$150.00</td>
<td>$57.7K</td>
<td>2.2K</td>
<td align="right">68</td>
</tr>
</tbody>
</table>

<h3>About EOG Resources</h3>
EOG Resources is an oil and gas producer with acreage in several US shale plays, primarily in the Permian Basin and the Eagle Ford. At the end of 2023, it reported net proven reserves of 4.5 billion barrels of oil equivalent. Net production averaged roughly 985,000 barrels of oil equivalent per day in 2023 at a ratio of 71% oil and natural gas liquids and 29% natural gas.
Following our analysis of the options activities associated with EOG Resources, we pivot to a closer look at the company's own performance.
<h3>EOG Resources's Current Market Status</h3>
<ul>
<li>With a volume of 1,265,323, the price of EOG is up 0.27% at $137.43. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 35 days.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for EOG Resources with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

EOG Resources Unusual Options Activity For January 16

Deep-pocketed investors have adopted a bullish approach towards Enphase Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in ENPH usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 17 extraordinary options activities for Enphase Energy. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 52% leaning bullish and 47% bearish. Among these notable options, 11 are puts, totaling $1,117,668, and 6 are calls, amounting to $297,956.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $50.0 and $75.0 for Enphase Energy, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Enphase Energy's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Enphase Energy's whale trades within a strike price range from $50.0 to $75.0 in the last 30 days. 
<h3>Enphase Energy Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737055992_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ENPH</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$2.55</td>
<td>$2.16</td>
<td>$2.3</td>
<td>$65.00</td>
<td>$183.9K</td>
<td>5.4K</td>
<td>833</td>
</tr>
<tr>
<td>ENPH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$12.7</td>
<td>$12.45</td>
<td>$12.46</td>
<td>$75.00</td>
<td>$179.7K</td>
<td>6.7K</td>
<td>612</td>
</tr>
<tr>
<td>ENPH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$12.5</td>
<td>$12.25</td>
<td>$12.5</td>
<td>$75.00</td>
<td>$177.5K</td>
<td>6.7K</td>
<td>276</td>
</tr>
<tr>
<td>ENPH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$12.8</td>
<td>$12.45</td>
<td>$12.53</td>
<td>$75.00</td>
<td>$153.0K</td>
<td>6.7K</td>
<td>468</td>
</tr>
<tr>
<td>ENPH</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$12.8</td>
<td>$12.55</td>
<td>$12.8</td>
<td>$75.00</td>
<td>$131.8K</td>
<td>6.7K</td>
<td>1.1K</td>
</tr>
</tbody>
</table>

<h3>About Enphase Energy</h3>
Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.
In light of the recent options history for Enphase Energy, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Enphase Energy's Current Market Status</h3>
<ul>
<li>With a trading volume of 2,772,157, the price of ENPH is down by -3.24%, reaching $63.7.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 19 days from now.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Enphase Energy, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

ENPH

Looking At Enphase Energy's Recent Unusual Options Activity

Oil and gas giant BP Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BP#NYSE">BP</a>) is reducing its workforce by 4,700 positions, which accounts for 5% of its employees, and eliminating more than 3,000 contractor jobs.
The oil giant aims to streamline its operations and reduce costs as part of an ongoing initiative to cut <a href="https://www.benzinga.com/news/earnings/24/05/38665532/why-bp-shares-are-trading-lower-premarket-today">$2 billion by the end of 2026.</a>
CEO Murray Auchincloss communicated these cuts to staff as part of the company&#8217;s ongoing cost-reduction efforts.
Since June 2024, BP suspended or paused 30 projects to concentrate on its most lucrative initiatives, according to a report from <a href="https://www.bloomberg.com/news/articles/2025-01-16/bp-eliminates-thousands-of-jobs-in-cost-cutting-effort-ceo-says?srnd=phx-industries-energy&amp;sref=TBDibEcD">Bloomberg</a>.
BP employs approximately 90,000 people worldwide, and while the cuts will affect several regions, specific details on country-level job losses have not been disclosed, reported <a href="https://www.bbc.com/news/articles/ckgy3ve1q69o">BBC</a>.
The restructuring comes under the leadership of CEO Auchincloss, who <a href="https://www.bp.com/en/global/corporate/news-and-insights/press-releases/murray-auchincloss-appointed-bp-chief-executive-officer.html">took the helm a year ago</a>.
The CEO, in his memo to the employees, stated that the company's pivot toward more digital capabilities, including artificial intelligence in engineering and marketing, would boost its operations.
Also Read: <a href="https://www.benzinga.com/25/01/43027582/toyota-subsidiary-agrees-to-16b-settlement-over-emission-data-fraud">Toyota Subsidiary Agrees To $1.6B Settlement Over Emission Data Fraud</a>
BP's decision to scale back its oil and gas production reduction targets for 2030 has been controversial, with some of the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/01/36829332/battleground-for-oil-majors-bp-activist-investor-calls-for-cut-in-green-energy-pled">investors supporting the decision</a>.
In 2020, BP set a goal to <a href="https://www.bp.com/en/global/corporate/news-and-insights/press-releases/from-international-oil-company-to-integrated-energy-company-bp-sets-out-strategy-for-decade-of-delivery-towards-net-zero-ambition.html">reduce its oil and gas</a> production by 40% by 2030.&nbsp;The goal was <a href="https://www.bp.com/en/global/corporate/sustainability/getting-to-net-zero/five-aims-to-get-bp-to-net-zero.html">abandoned in October 2024</a>. 
Earlier this week, BP said production in its fiscal fourth quarter is expected to be <a href="https://www.benzinga.com/25/01/42971311/bp-warns-of-lower-oil-gas-output-in-fourth-quarter-update">lower than in the third quarter</a>. 
For the fourth quarter, the company anticipates a decline in upstream production compared to the previous quarter, with reductions in both oil and gas &amp; low-carbon energy output.
In the gas and low-carbon energy segment, realizations are expected to improve by $0.1 to $0.2 billion, driven by fluctuations in non-Henry Hub natural gas prices.
In the oil production and operations sector, BP predicts a negative impact on realizations of $0.2 billion to $0.4 billion, primarily due to price lags, especially in the Gulf of Mexico and UAE.
The company&#8217;s operating revenues for the third quarter came in at $47.254 billion, missing the <a href="https://www.benzinga.com/news/earnings/24/10/41598840/bp-stock-drops-as-q3-revenue-misses-mark-production-declines-debt-rises">consensus of $52.557 billion</a>.
Investors can gain exposure to the stock via Texas Capital Texas Oil Index ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OILT#NYSE">OILT</a>) and Amplify Natural Resources Dividend Income ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NDIV#NYSE">NDIV</a>).
BP Price Action: BP shares are trading higher by 1.55% at $31.79 at publication Thursday.
Read Next: <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43037588/stocks-pause-chipmakers-rise-gold-hits-2-month-highs-whats-driving-markets-thursday">• Stocks Pause, Chipmakers Rise, Gold Hits 2-Month Highs: What&#8217;s Driving Markets Thursday?</a>
Photo: Jon Lyall via Shutterstock

Commodities

NDIV

OILT

BP Slashes Workforce By 5% To Reach $2 Billion In Savings Goal

Atomera Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATOM#NASDAQ">ATOM</a>) shares are trading lower Thursday potentially continuing a momentum-driven decline as markets react to <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43001512/inflation-rises-to-29-in-december-core-slows-yet-rising-energy-costs-put-feds-target-at-risk">mixed inflation data for December</a>.
What To Know: The data showed consumer prices rising 2.9% year-over-year, marking the highest annual rate since July 2024. The Consumer Price Index (CPI) increase, driven largely by a 2.6% rise in the energy index, has renewed concerns over the Federal Reserve&#8217;s ability to achieve its 2% inflation target.
While core inflation, excluding food and energy, rose 3.2% annually—slightly below estimates—monthly core prices climbed 0.2%, in line with expectations.
Market sentiment reflected optimism in equity indices, with S&amp;P 500 futures up 1.5% and Nasdaq 100 contracts gaining 1.6%. However, Atomera shares diverged, likely impacted by broader concerns about rate-sensitive sectors and continued negative sentiment around the stock.
Treasury yields also fell following the inflation report, with the two-year yield dropping 9 basis points to 4.28% while the U.S. dollar weakened. Despite these broader market moves, Atomera's sharp decline may suggest company-specific pressures are compounding its struggles amid macroeconomic uncertainty.
ATOM Price Action: Atomera shares were down 20.2% at $8.91 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011625&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="1024" height="547" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16140018/Screenshot-2025-01-16-at-13.59.43-1024x547.png" alt="" class="wp-image-737532" style="width:469px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16140018/Screenshot-2025-01-16-at-13.59.43-1024x547.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16140018/Screenshot-2025-01-16-at-13.59.43-300x160.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16140018/Screenshot-2025-01-16-at-13.59.43-768x410.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16140018/Screenshot-2025-01-16-at-13.59.43.png 1510w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/25/01/43038294/can-ai-solve-cannabis-medicines-data-problem-new-tech-initiative-aims-to-streamline-research-and-treatments">Can AI Solve Cannabis Medicine&#8217;s Data Problem? New Tech Initiative Aims To Streamline Research And Treatments</a></li>
</ul>
Image: Shutterstock/ Atomic62 Studio.

Movers

ATOM

Atomera Shares Plunge Amid Broader Market Movements: What's Going On?

On Wednesday, ImmunityBio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>) released progress in its ongoing FDA discussions regarding three areas of its clinical development pipeline in non-muscle invasive bladder cancer (NMIBC) and non-small <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b43017050/immunitybio-provides-regulatory-update-on-anticipated-fda-submissions-in-2025-following-meeting-wi" rel="noreferrer noopener">cell lung cancer (NSCLC)</a>.
<ul>
<li>NMIBC BCG Unresponsive Papillary Disease: ImmunityBio is preparing to submit a supplemental Biologics License Application (sBLA) in 2025 for its treatment targeting Bacillus Calmette-Guérin (BCG) unresponsive NMIBC in the papillary indication. As published in the Chamie 2022 NEJM publication, the primary endpoint was met with a disease-free rate of 55% at 12 months, 51% at 18 months, and 48% at 24 months.</li>
<li>In addition, patients receiving Anktiva+BCG achieved a 93% avoidance of cystectomy with a median follow-up of 20.7 months.</li>
<li>Alternative Source of BCG: In collaboration with the Serum Institute of India, ImmunityBio plans a regulatory submission for an alternative source of BCG in the <a href="https://www.benzinga.com/general/biotech/24/05/38619196/serum-institute-of-india-inks-large-scale-supply-deal-for-bcg-use-in-immunitybios-bladder-cancer-" target="_blank" rel="noreferrer noopener">first quarter of 2025</a>. Serum Institute&#8217;s GMP capacity to manufacture large-scale volumes of BCG, already tested for safety and efficacy in clinical trials in Europe in subjects with NMIBC, aims to address the shortage of BCG.</li>
</ul>
Price Action: IBRX stock is up 18.6% at $2.835 at last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/contracts/25/01/43026684/symbotic-soars-after-robotics-deal-with-walmart-whats-going-on" target="_blank" rel="noreferrer noopener">Symbotic Soars After Robotics Deal With Walmart &#8211; What&#8217;s Going On?</a></li>
</ul>
Photo via Shutterstock.

Biotech

Equities

IBRX

ImmunityBio Stock Trading Higher On Updates From Bladder Cancer Trials: Details

Katapult Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KPLT#NASDAQ">KPLT</a>) shares are trading higher by 63% to $11.41 during Thursday&#8217;s session after the company reported <a href="https://www.benzinga.com/pressreleases/25/01/g43025830/katapult-provides-update-on-fourth-quarter-performance-gross-originations-grow-double-digits-year-">$75.2 million in gross originations</a> for the fourth quarter of 2024, up 11.3% year-over-year and surpassing its November forecast of 6-8% growth.
What To Know: Katapult says this marks the ninth consecutive quarter of annual growth and the second-highest gross originations in the company's history. 
This performance was fueled by a 50% year-over-year increase in lease applications, with significant contributions from both new (51%) and repeat customers (61.5% of originations). Additionally, the company says Katapult Pay saw a 52% surge in gross originations. 
CEO Orlando Zayas attributed the success to strong holiday engagement and the evolving Katapult ecosystem. Zayas expressed optimism for sustained growth in 2025, with final financial results to be announced in March.
Read Also: <a href="https://www.benzinga.com/news/management/25/01/43029622/whats-going-on-with-bigbear-ai-stock-thursday-2">What&#8217;s Going On With BigBear.AI Stock Thursday?</a>
<h2 class="wp-block-heading">How To Buy KPLT Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Katapult Holdings&#8217; case, it is in the Financials sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, KPLT has a 52-week high of $23.54 and a 52-week low of $5.08.

KPLT

Why Katapult Holdings (KPLT) Shares Are Up 63% Today

Whales with a lot of money to spend have taken a noticeably bullish stance on Verona Pharma.
Looking at options history for Verona Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNA#NASDAQ">VRNA</a>) we detected 14 trades.
If we consider the specifics of each trade, it is accurate to state that 64% of the investors opened trades with bullish expectations and 28% with bearish.
From the overall spotted trades, 7 are puts, for a total amount of $319,653 and 7, calls, for a total amount of $262,865.
<h3>Predicted Price Range</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $45.0 to $60.0 for Verona Pharma during the past quarter. 
<h3>Volume &amp; Open Interest Trends</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Verona Pharma's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Verona Pharma's significant trades, within a strike price range of $45.0 to $60.0, over the past month.
<h3>Verona Pharma Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737054978_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>VRNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$3.7</td>
<td>$3.7</td>
<td>$3.7</td>
<td>$55.00</td>
<td>$75.1K</td>
<td>0</td>
<td>1.0K</td>
</tr>
<tr>
<td>VRNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$4.3</td>
<td>$4.2</td>
<td>$4.3</td>
<td>$55.00</td>
<td>$68.3K</td>
<td>0</td>
<td>715</td>
</tr>
<tr>
<td>VRNA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$5.4</td>
<td>$5.1</td>
<td>$5.4</td>
<td>$45.00</td>
<td>$56.9K</td>
<td>2.3K</td>
<td>80</td>
</tr>
<tr>
<td>VRNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$4.8</td>
<td>$4.8</td>
<td>$4.8</td>
<td>$55.00</td>
<td>$46.5K</td>
<td>0</td>
<td>420</td>
</tr>
<tr>
<td>VRNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$6.1</td>
<td>$5.2</td>
<td>$5.1</td>
<td>$55.00</td>
<td>$41.8K</td>
<td>0</td>
<td>82</td>
</tr>
</tbody>
</table>

<h3>About Verona Pharma</h3>
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
Following our analysis of the options activities associated with Verona Pharma, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of Verona Pharma</h3>
<ul>
<li>Currently trading with a volume of 1,114,755, the VRNA's price is up by 5.52%, now at $53.09. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 42 days.</li>
</ul>
<h3>Professional Analyst Ratings for Verona Pharma</h3>
A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $66.33333333333333.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Truist Securities downgraded its action to Buy with a price target of $57. 
&#x2A; Consistent in their evaluation, an analyst from Wells Fargo keeps a Overweight rating on Verona Pharma with a target price of $74. 
&#x2A; An analyst from Roth MKM downgraded its action to Buy with a price target of $68. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Verona Pharma options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

VRNA

Verona Pharma's Options Frenzy: What You Need to Know

NFT Limited (MI) has released an update. NFT Limited reported a significant increase in total assets from $73.7 million at the end of 2023 to $86.8...

Comments

NFT

Noticias

Últimas noticias sobre NFT (AMEX:MI) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL